AI-generated summary
The authors describe one 39-year-old African-American man with mild rhinophyma who was treated with two sessions of fractionated carbon dioxide laser, and they review the literature on this approach. They report that the treatment was successful and suggest it may be a safe and effective option for patients with darker skin. The evidence rests on a single case report, so the findings cannot be generalized.
- Who or what was studied
- One 39-year-old African-American man (Fitzpatrick VI) with long-standing, mild rhinophyma
- Limits stated in the abstract
- The report describes a single patient, and the authors' suggestion of safety and efficacy in skin of color is not tested in a larger sample.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Case report. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.